Note: Ingredients listed on restricted chemical lists
EC/CAS
272-697-1/68909-20-6
Name of the chemical
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica
Concentration
20-<50%
EC/CAS
208-762-8/540-97-6
Name of the chemical
D6
Concentration
0,1-<1%
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
0,1-<1%
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
0,01-<0,079%
General Information
Version
9.0
Revision date
2024-10-08
Product name
Adisil pink - component B Duplicating silicone
1.2.1 Relevant identified uses
Moulding diverse objects
supplier name
SILADENT Dr. Böhme & Schöps GmbH
Emergency telephone
+49 (0) 53 21 / 37 79 - 0
Icons in SDS
Company Information
company name
SILADENT Dr. Böhme & Schöps GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@siladent.de
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
Health hazards
STOT RE 2 H373 May cause damage to organs through prolonged or repeated exposure. (Target Organs Lung)
Supplemental label elements
EUH210 Safety data sheet available on request. EUH066 Repeated exposure may cause skin dryness or cracking
Physical hazards
No specific recommendations Health Hazards: Inhalation Surface treated silica: When encapsulated in a polymer, is not expected to pose a health hazard when processed under normal conditions of use Although classified according to EC criteria, this product is exempt from labelling according to article 23 and Annex 1 (section 1.3.4.1) of regulation (CE) n°1272/2008 Eye contact: Skin Contact No specific symptoms noted Repeated exposure may cause skin dryness or cracking Ingestion No specific symptoms noted
Other Health Effects
No other information noted.
Environmental hazards
No hazard identified as the maximum bioavailable concentration of Octamethylcyclotetrasiloxane (D4) is lower than the classification cut-off value (see of this SDS)
Results of PBT and vPvB assessment
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB). Endocrine Disruption - Health The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine Disruption - Environment The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Other hazards
Chemical compounds containing silicon - hydrogen bonds (SiH). This product may generate hydrogen gas. For further information, refer to section 10: "Stability and Reactivity".
2.1 Classification of the substance or mixture
The product has been classified according to the legislation in force. Classification according to Regulation (EC) No 1272/2008 as amended. Health Hazards STOT RE 2 H373 May cause damage to organs through prolonged or repeated exposure. (Target Organs: Lung)
